ENT

Your Article Summary

See Latest Articles

Diagnosis of second head and neck tumors in primary laryngeal SCC is an indicator of overall survival and not associated with poorer overall survival: A single centre study in 987 patients
Journal of Surgical Oncology, 10/05/09

Farhadieh RD et al. – The results suggest that HNSCC–SPT should not be viewed as an adverse prognostic factor. Reclassifications of UAD–SPTs into HNSCC–SPT and non–HNSCC–SPT better reflects their clinical behavior and prognosis.

Today in Head and Neck...keeping you current

Receive free subspecialty "5-minute updates" via email

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: Results from a phase II prospective trial
Journal of Clinical Oncology, 11/25/09

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/12/09

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09

See All of Head and Neck

Today in Larynx/Trachea/Airway...keeping you current

Receive free subspecialty "5-minute updates" via email

Thyroid lymphoma and airway obstruction – is there a rationale for surgical management?
International Journal of Clinical Practice, 10/19/09

Airway management and initial resuscitation of the trauma patient
Current Opinion in Critical Care, 11/10/09

Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab
Journal of Clinical Oncology, 11/12/09

See All of Larynx/Trachea/Airway